Thursday, 21 January 2021
This website uses cookies. By using our site you agree to our privacy policy
Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Contributing Faculty
    • Supporters
    • Collaborators
    • Site Map
    • Contact Us
    • Accreditation
    • Disclosures
    • Press Room
  • Resources
    • FAQ Library
    • Newsletters
    • Clinical Pearls Podcasts
    • Clinical Expert Commentaries
    • Clinical Trial Highlights
    • Downloadable Slide Sets
      • ONS 2016
      • ASCO GI 2016
    • Journal Abstracts
    • Articles
    • COVID-19 Resources
  • Tools
  • CE Education
    • Practice Essentials in Pancreatic Cancer
    • Meeting Highlights
    • Accredited E-Newsletter Series
    • How Will I Treat This Patient? – Case Series
    • Shining Light on Pancreatic Cancer
    • New Treatment Paradigms Monograph
    • PROMISING PROGRESS: Improving Knowledge of Emerging Treatments in Advanced Pancreatic Cancer
    • Clinical Dialogues™ in Pancreatic Cancer
    • Research, Advocacy and Practice
  • CE for Nurses
  • Advocacy
  • Safe and Effective Prescribing of Opioid Analgesics: A Hands-on, Case-based Clinical Curriculum in Oncology
  • Your Patient is Diagnosed with Metastatic Pancreatic Cancer: Do You Know the Best Treatment Options?
  • The Current State of Personalized Medicine: Biomarkers in Pancreatic Cancer
  • MediCom Oncology Clinical Pearls Podcasts

What's New

CE Education
Treating Advanced Metastatic Pancreatic Cancer: Current Challenges and Future Opportunities
Vincent J. Picozzi, Jr., MD, MMM
CE Education
A Panel Discussion of Critical New Advances in Pancreatic Cancer from ASCO-GI to the 2019 ASCO Annual Meeting
Eileen M. O’Reilly, MD - Chairperson; Tanios Bekaii-Saab, MD, FACP; and Andrea Wang-Gillam, MD, PhD
Newsletters
Promising Clinical Trials to Look for when Treating Patients with Pancreatic Cancer
Eileen M. O'Reilly, MD
CE Education
Clinical Trial Tracker: An Update on Promising Phase 2 and 3 Clinical Trials in Pancreatic Cancer
J. Randolph Hecht, MD
Knowledge Library
What is the best sequencing approach for second-line therapy when using FOLFIRINOX in the first line?
Tanios Bekaii-Saab, MD, FACP
Clinical Expert Commentary
One Major Healthcare System’s Approach to Standardized Care Pathways for the Treatment of Pancreatic Cancer
Federico A. Sanchez, MD
Knowledge Library
What is the future role of maintenance therapy in pancreatic cancer?
Vincent Picozzi, Jr., MD, MMM
Clinical Pearls Podcasts
Listen or download these brief audio clips to use at the point of care in your practice!
FAQ Library
Untitled Document
MediCom Oncology
Subscribe Today to join our MediCom Oncology Digest
mailing list!
Your email address will not be shared with any third party, nor sold.

Meeting Highlights

Newsletter

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | EmergingSolutionsinPain.com | MediComWorldwide.com

©2021 MediCom Worldwide, Inc. All rights reserved
  • Privacy, Terms, and Conditions
  • Contact Us